Medical Device Testing Services Market To Reach $20.2 Billion By 2033

Medical Device Testing Services Market Growth & Trends

The global medical device testing services market size is expected to reach USD 20.2 billion by 2033, registering a CAGR of 8.5% from 2026 to 2033, according to a new report by Grand View Research, Inc. Increasing complexity in product design and stringent government regulations are driving demand for medical device testing services.

Significant rise in preclinical spending is a recent trend among pharmaceutical and medical device companies, which is expected to significantly contribute to market growth. According to the global health center, for pharmaceuticals, supporting preclinical research required 73 months and cost USD 7 million for biologics, it took 47 months and cost USD 6.3 million.

With modern medical devices offering a host of complex functions, the need for appropriate tests to check the compliance of the device with regulatory requirements is becoming vital. In order to meet the requirement of enhanced accuracy, ease of use, and durability, medical devices need to undergo extensive tests. This is expected to deliver competitive advantage to manufacturers.

On the other hand, an increase in the need for production efficiency and safety and rising regulatory requirements for medical devices are some of the major factors driving the market growth. Regulatory bodies such as the European Medicines Agency, U.S. Food and Drug Administration, Therapeutic Goods Administration, and other country regulatory bodies require documentation and testing to certify that medical devices meet efficacy and safety standards prior they can be sold and marketed to patients and healthcare providers.

The COVID-19 pandemic has created an unprecedented demand for medical device testing services. This is largely due to the increasing demand for COVID-10 related products such as masks, PPE, & respiratory equipments. Besides, countries such as Mexico, Spain, and France have published pertinent specifications and standards, namely the UNE 0064-1, UNE 0064-2, AFNOR-SPEC-S76 & UNE 0065, which must be met until a mask can be sold.

 Request a free sample copy or view report summary: Medical Device Testing Services Market Report

Medical Device Testing Services Market Report Highlights

• The biocompatibility testing services segment led the market, accounting for the largest revenue share of 46.3% in 2025. The segment's dominance is attributed to mandatory biological safety evaluations for a broad range of medical devices prior to regulatory approval.

• The commercial segment led the market with the largest revenue share of 43.7% in 2025. The segment's dominance is attributed to the increasing global medical device production, expanding quality assurance requirements, post-approval design modifications, manufacturing scale-up activities, and ongoing sterility, microbiological, and package validation testing required to maintain regulatory compliance throughout the product lifecycle.

• The class II segment led the market with the largest revenue share of 49.3% in 2025. The segment's leadership is driven by the broad range of moderate-risk medical devices that require comprehensive biological safety, chemistry, microbiology, packaging validation, and performance testing prior to commercialization.

• The cardiovascular devices segment led the market, with a revenue share of 21.6% in 2025. The stringent testing requirements for cardiovascular implants and interventional devices, including biological evaluation, material characterization, sterility validation, and package integrity assessments, significantly contribute to market demand.

• The medical device manufacturers segment led the market with the largest revenue share of 78.1% in 2025. The segment's dominance is attributed to increased investment in product development, regulatory compliance, and quality assurance among medical device manufacturers.

• Asia Pacific accounted for the largest market share of 41.6% in 2025. The evolving medical device testing services are expected to increase the market demand in the region, owing to established healthcare infrastructure with government initiatives.

Medical Device Testing Services Market Segmentation

Grand View Research has segmented the global medical device testing services market report based on service, phase, device class, industry application, end use, and region:

Medical Device Testing Services Service Outlook (Revenue, USD Billion, 2021 - 2033)                          

• Biocompatibility Testing Services             

  • Material / Chemical Characterization

  • Cytotoxicity Testing

  • Sensitization Testing

  • Irritation & Reactivity Testing

  • Systemic Toxicity Testing

  • Hemocompatibility Testing

  • Implantation Testing

  • Pyrogenicity Testing

  • Others

• Chemistry Testing Services          

  • Analytical Method Development & Validation

  • Residuals & Contaminant Analysis

  • Stability & Degradation Studies

  • Other Analytical Chemistry Services

• Microbiology QC Testing Services             

  • Bioburden Determination

  • Bacterial Endotoxin Testing

  • Sterility Testing & Validation

  • Others

• Package Validation Services        

Medical Device Testing Services Phase Outlook (Revenue, USD Billion, 2021 - 2033)                              

• Preclinical           

  • In Vivo Testing

  • Ex Vivo Testing

  • In Vitro Testing

• Clinical 

• Commercial       

Medical Device Testing Services Device Class Outlook (Revenue, USD Billion, 2021 - 2033)                 

• Class I   

• Class II 

• Class III

Medical Device Testing Services Industry Application Outlook (Revenue, USD Billion, 2021 - 2033)                 

• Cardiovascular Devices 

• Orthopedic Devices        

• Dental Devices 

• Neurological Devices     

• Ophthalmic Devices       

• General Surgical Devices              

• Aesthetic & Dermatology Devices            

• Others 

Medical Device Testing Services End Use Outlook (Revenue, USD Billion, 2021 - 2033)                         

• Medical Device Manufacturers 

• CRO & CDM

• Others 

Medical Device Testing Services Regional Outlook (Revenue, USD Billion, 2021 - 2033)

• North America

  • U.S.

  • Canada

  • Mexico

• Europe

  • UK

  • Germany

  • France

  • Italy

  • Spain

  • Denmark

  • Sweden

  • Norway

  • Netherlands

  • Belgium

  • Switzerland

• Asia Pacific

  • Japan

  • China

  • India

  • Australia

  • Thailand

  • South Korea

  • Malaysia

  • Indonesia

  • Singapore

  • Philippines

  • Thailand

• Latin America

  • Brazil

  • Argentina

  • Colombia

  • Chile

• Middle East & Africa

  • South Africa

  • UAE

  • Saudi Arabia

  • Kuwait

  • Qatar

  • Oman

List of Key Players of Medical Device Testing Services Market

• SGS SA

• Laboratory Corporation of America Holdings

• Sotera Health Company (Nelson Laboratories, LLC)

• TÜV SÜD

• Charles River Laboratories

• Element Minnetonka

• Eurofins Scientific

• Pace Analytical Services LLC

• Intertek Group Plc

• North America Science Associates Inc. (NAMSA)